{"id":3347,"date":"2026-03-10T08:53:41","date_gmt":"2026-03-10T08:53:41","guid":{"rendered":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/?page_id=3347"},"modified":"2026-03-20T04:42:00","modified_gmt":"2026-03-20T04:42:00","slug":"catheter-directed-thrornbolysis","status":"publish","type":"page","link":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/treatment\/catheter-directed-thrornbolysis\/","title":{"rendered":"Catheter-Directed Thrornbolysis"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Catheter-Directed Thrornbolysis<\/h1>
Home<\/a>\"\"

Catheter-Directed Thrornbolysis<\/p><\/div><\/div>

\"\"+91 90033 03373<\/span><\/a><\/div><\/div><\/div><\/section><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Catheter-Directed Thrornbolysis<\/h1>
Home<\/a>\"\"

Catheter-Directed Thrornbolysis<\/p><\/div><\/div><\/div><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

procedure steps<\/h1>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

1. Preparing and Evaluating Patients<\/h3>

In order to validate the location and degree of thrombus, patients receive comprehensive clinical evaluation and imaging studies prior to the treatment. Medication may be changed, and informed consent is acquired.<\/p><\/div><\/div>

2. Venous Access<\/h3>

Depending on the location of the thrombus, venous access is usually obtained via the common femoral, popliteal, or jugular vein under sterile procedure and local anesthetic. To guarantee a safe puncture, ultrasound guidance is often utilized.<\/p><\/div><\/div>

3. Placement of Catheters<\/h3>

Using fluoroscopic or ultrasound guidance, a multi-side-hole infusion catheter is advanced over a guidewire that has been inserted through the needle to the thrombus location.<\/p><\/div><\/div>

4. Delivery of the First Thrombolytic Agent<\/h3>

Initially, thrombolytic medicines (such as alteplase\/tPA) may be delivered directly into the thrombus using a "pulse spray" approach to increase penetration by creating fissures.<\/p><\/div><\/div>

5. Constant Thrombolytic Infusion<\/h3>

Following the initial spray, the thrombolytic agent is continuously infused through the catheter for 12 to 24 hours or longer, depending on the patient's reaction and the clot burden, under close observation.<\/p><\/div><\/div>

6. Adjunctive Methods<\/h3>

Thrombus dissolving can be enhanced by mechanical thrombectomy devices like AngioJet or ultrasound-assisted thrombolysis (e.g., EKOS catheter), which increases effectiveness and shortens infusion time.<\/p><\/div><\/div>

7. Observing<\/h3>

During infusion, vital signs, coagulation parameters, and neurological condition are closely monitored in order to identify and treat bleeding or other issues as soon as possible.<\/p><\/div><\/div>

8. Finalization and Removal of the Catheter<\/h3>

Following enough clot destruction, the thrombolytic infusion is discontinued, the catheter and sheath are carefully withdrawn, and closure devices or manual compression are used to establish hemostasis.<\/p><\/div><\/div>

9. Imaging and Follow-Up After the Procedure<\/h3>

To assess clot resolution, further imaging is performed. If vein stenosis continues, additional endovascular treatments like angioplasty or stenting may be carried out.<\/p><\/div><\/div>

10. Anticoagulation and Treatment<\/h3>

In order to prevent re-thrombosis and evaluate symptom improvement, patients typically continue on anticoagulant treatment after the surgery and need close clinical follow-up.<\/p><\/div><\/div><\/div><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

disease treated<\/h1>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n
\n
\n
\n \"\"\n <\/div>\n
\n
Deep Vein Thrombosis<\/h6>\n

Lorem Ipsum is simply dummy text of the printing and typesetting industry.<\/p>\n <\/div>\n <\/div>\n <\/div>\n\n <\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

suitable for<\/h1>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Acute Iliofemoral Deep Vein Thrombosis<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CDT is particularly beneficial for patients with acute thrombosis (less than 21 days after the onset of symptoms) involving the iliac and proximal femoral veins. This group is more likely to experience severe symptoms of post-thrombotic syndrome (PTS).<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
High Risk of Post-Thrombotic Syndrome<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Compared to anticoagulation alone, CDT lowers the risk or severity of PTS by protecting venous valves and reducing clot burden.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Phlegmasia Cerulea Dolens with Limb-Threatening Thrombosis<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

recommended in extreme situations where venous gangrene or impaired blood flow pose a risk of limb ischemia and necessitate quick clot removal.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Subacute and Chronic Iliofemoral DVT<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

When conventional treatment is ineffective, very symptomatic individuals with subacute or chronic venous clots may be candidates for CDT.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Acute or Subacute Inferior Vena Cava (IVC) Thrombosis<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The term “acute” or “subacute” inferior vena cava (IVC) thrombosis refers to thrombosis that affects the major central veins, especially if it is symptomatic or poses a risk to limbs.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Individuals with Rapid Symptom Progression or Thrombus Extension Even with anticoagulation<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CDT is used to actively lyse the thrombus when anticoagulation is not enough.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Younger Individuals with Low Bleeding Risk and Long Life Expectancy<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/g><\/rect><\/clipPath><\/defs><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The long-term decrease in PTS and enhanced venous patency provided by CDT are particularly beneficial to these individuals.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Carefully Chosen Patients at Low Risk of Bleeding<\/h6>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Recent major surgery, recent stroke, and active internal bleeding are absolute contraindications. Benefits and relative hazards must be taken into account.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

benefits<\/h1>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Quick Restoration of Blood Flow<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

By immediately delivering thrombolytic drugs to the clot location, CDT promptly restores circulation and relieves symptoms like pain, edema, and limb dysfunction.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Decreased Post-Thrombotic Syndrome (PTS) Risk<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Compared to anticoagulation alone, CDT significantly reduces the risk and severity of chronic PTS by dissolving more of the clot burden and preserving venous valve function.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Reduced Rates of Recurrent<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

DVT CDT lowers the residual clot load, which results in fewer deep vein thrombosis episodes and venous disease rehospitalizations in the future.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Minimal Invasiveness and Decreased Risk of Bleeding<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

By targeting the clot with smaller doses of lytic medications than systemic thrombolysis, CDT reduces the risk of significant bleeding and other systemic effects.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Enhanced Life Quality and Functional Results<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Vein patency, symptom alleviation, and long-term capacity to resume daily activities with fewer chronic problems are all improved in patients treated with CDT.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Reduced Hospital Stays and Quicker Recuperation<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Compared to standard surgical thrombectomy, CDT frequently results in shorter hospital stays and faster recovery times with fewer skin incisions that don’t require stitches.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Economical for Patients Who Have Been Carefully Selected<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Particularly for younger patients with longer life expectancies, CDT may lower long-term impairment, recurrence rates, and expenses related to PTS and recurrent hospital stays.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

post-treatment recovery<\/h1>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Hospitalization and Observation<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
In order to closely monitor vital signs, hemorrhage, and overall response to thrombolytic therapy, patients usually stay in the hospital for one to three days, frequently spending one to two days in the intensive care unit (ICU).<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Duration of Thrombolytic Infusion<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
Depending on the size of the clot and the clinical response, the clot-dissolving drug is often given through the catheter for 12 to 24 hours or up to 72 hours.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
During infusion, constant observation is necessary to identify problems early.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
After-Procedure Care<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
Following the infusion, the catheter is taken out and the puncture site is compressed to stop bleeding.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
Compression stockings are typically used to support venous return and lessen edema.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Recuperation and Activity<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
Walking and mild exercise are recommended shortly after treatment to avoid stasis.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
In order to lower the risk of bleeding, strenuous activities are first limited. While recovery times vary, most patients see noticeable symptom improvement in a few of weeks.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Anticoagulation and Monitoring<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
To stop future clots, patients take anticoagulants for three to six months after the operation. Imaging and scheduled follow-up consultations assess vein patency and detect any remaining clots.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Safety and Complications<\/h6>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
The most frequent side effect is bleeding, which carries a lesser risk than systemic thrombolysis.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
\"\"<\/figure>
During hospitalization, careful observation of the vascular access site and neurologic state is essential.<\/h6><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Schedule Your
\nConsultation Today!<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tget an appointment<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

procedure steps disease treated suitable for Acute Iliofemoral Deep Vein Thrombosis CDT is particularly beneficial for patients with acute thrombosis (less than 21 days after the onset of symptoms) involving the iliac and proximal femoral veins. This group is more likely to experience severe symptoms of post-thrombotic syndrome (PTS). High Risk of Post-Thrombotic Syndrome Compared […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2735,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3347","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/pages\/3347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/comments?post=3347"}],"version-history":[{"count":26,"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/pages\/3347\/revisions"}],"predecessor-version":[{"id":5604,"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/pages\/3347\/revisions\/5604"}],"up":[{"embeddable":true,"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/pages\/2735"}],"wp:attachment":[{"href":"https:\/\/demo.essenceofdesigns.com\/drjennygandhi\/wp-json\/wp\/v2\/media?parent=3347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}